MrC's Smallcap Sweeps for May 2020
Posted: May 1st, 2020, 7:33 am
Smallcap Sweep. 01-May-20
Shield Therapeutics (STX) guides FY(Dec) rev only £0.7m due to AEGIS-H2H study fail and the agreement to repay Norgine €2.5m. Has cash to Q1 2021.
Kromek (KMK) guides FY(Apr) flat due to contract delays and lockdown. Co "good visibility over future revenues, and it has a healthy pipeline of projects." Cash at hand £10m. No guidance.
Arden Partners (ARDN) H1 trading: "materially higher corporate finance revenues, higher retainer levels but lower equity commissions. The equity trading operation suffered material losses." Guides loss but down YoY. Has cash well in excess of its regulatory requirements. Continues to sign up quality clients.
Cropper(James) (CRPR) guides FY(March) adj pretax well ahead of market expectations at over £6m. Guidance: Q1 large negative impact and loss making. Q2-3 continues to be loss-making, albeit with some recovery evident. Q4 being back into profitability.
Quadrise Fuels (QFI) cost cuts means has cash to mid Q2 2021. Equipment and MSAR fuel for the first phase pilot plant trial in Morocco now on site, awaiting end of site lockdown.
Avacta Group (AVCT) collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix's tech. Aims for clinical validation, regulatory approval and manufacturing in June. "We believe that the BAMS test will be hugely attractive as an adjunct to PCR testing because it uses laboratory equipment that is already in hospital labs."
SpaceandPeople (SAL) gets £1m covid loan, will allow the Group to trade through the current period of venue closures.
LSL Property Services (LSL) new CEO, old one thanked.
Immedia Group (IME) CEO scarpers. He is thanked.
Gulf Marine Services (GMS) FY rev down 13%, adj loss $20m ($5.1m). Q1 adj EBITDA slightly better than plan. Needs new loan signed by end June or it's lights out. What a crock.
Notes (do not rely on the data)
STX: Price=124.5. Cap=146m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Shield Therapeutics is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.
KMK: Price=20. Cap=69m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Kromek Group is the developer of radiation detectors based on cadmium zinc telluride, providing improved detection and characterisation capabilities within the medical imaging, nuclear detection, and security screening markets.
ARDN: Price=6.15. Cap=2m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Arden Partners is a multi-service stockbroker. The Company provides financial services to corporate and institutional clients. Its business divisions are Equities Division and Corporate Finance Division.
James: Price=NA. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
QFI: Price=1.51. Cap=15m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Quadrise Fuels International is engaged in the manufacturing and marketing of emulsion fuel for use in power generation, industrial and marine diesel engines and steam generation applications.
AVCT: Price=95.5. Cap=199m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Avacta Group is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.
SAL: Price=6.75. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
SpaceandPeople is engaged in marketing and selling of promotional and retail licensing space on behalf of shopping centers. The company’s segments are Promotional Sales and Retail with geographic locations in the United Kingdom and Germany.
LSL: Price=161. Cap=168m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
LSL Property Services provides residential property services to consumers. Some of its offerings include residential sales, lettings, surveying, conveyancing and advice on mortgages and non-investment insurance products.
IME: Price=8. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Immedia Group provides music and communications solutions helping companies in retail, banking, leisure and hospitality, energy, sport, tourism, and education achieving customer’s expectations by creating sensory content and marketing communications.
GMS: Price=6.2. Cap=22m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Gulf Marine Services is a provider of self-propelled, self-elevating accommodation jack-up barges in the Middle East and globally. The Company's business segments are Small Class vessels, Mid-Size Class vessels, Large Class vessels, and Other vessels.
* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk/index.aspx?limit=-1
@MrContrarian
read it first on Twitter
Shield Therapeutics (STX) guides FY(Dec) rev only £0.7m due to AEGIS-H2H study fail and the agreement to repay Norgine €2.5m. Has cash to Q1 2021.
Kromek (KMK) guides FY(Apr) flat due to contract delays and lockdown. Co "good visibility over future revenues, and it has a healthy pipeline of projects." Cash at hand £10m. No guidance.
Arden Partners (ARDN) H1 trading: "materially higher corporate finance revenues, higher retainer levels but lower equity commissions. The equity trading operation suffered material losses." Guides loss but down YoY. Has cash well in excess of its regulatory requirements. Continues to sign up quality clients.
Cropper(James) (CRPR) guides FY(March) adj pretax well ahead of market expectations at over £6m. Guidance: Q1 large negative impact and loss making. Q2-3 continues to be loss-making, albeit with some recovery evident. Q4 being back into profitability.
Quadrise Fuels (QFI) cost cuts means has cash to mid Q2 2021. Equipment and MSAR fuel for the first phase pilot plant trial in Morocco now on site, awaiting end of site lockdown.
Avacta Group (AVCT) collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix's tech. Aims for clinical validation, regulatory approval and manufacturing in June. "We believe that the BAMS test will be hugely attractive as an adjunct to PCR testing because it uses laboratory equipment that is already in hospital labs."
SpaceandPeople (SAL) gets £1m covid loan, will allow the Group to trade through the current period of venue closures.
LSL Property Services (LSL) new CEO, old one thanked.
Immedia Group (IME) CEO scarpers. He is thanked.
Gulf Marine Services (GMS) FY rev down 13%, adj loss $20m ($5.1m). Q1 adj EBITDA slightly better than plan. Needs new loan signed by end June or it's lights out. What a crock.
Notes (do not rely on the data)
STX: Price=124.5. Cap=146m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Shield Therapeutics is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.
KMK: Price=20. Cap=69m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Kromek Group is the developer of radiation detectors based on cadmium zinc telluride, providing improved detection and characterisation capabilities within the medical imaging, nuclear detection, and security screening markets.
ARDN: Price=6.15. Cap=2m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Arden Partners is a multi-service stockbroker. The Company provides financial services to corporate and institutional clients. Its business divisions are Equities Division and Corporate Finance Division.
James: Price=NA. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
QFI: Price=1.51. Cap=15m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Quadrise Fuels International is engaged in the manufacturing and marketing of emulsion fuel for use in power generation, industrial and marine diesel engines and steam generation applications.
AVCT: Price=95.5. Cap=199m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Avacta Group is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.
SAL: Price=6.75. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
SpaceandPeople is engaged in marketing and selling of promotional and retail licensing space on behalf of shopping centers. The company’s segments are Promotional Sales and Retail with geographic locations in the United Kingdom and Germany.
LSL: Price=161. Cap=168m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
LSL Property Services provides residential property services to consumers. Some of its offerings include residential sales, lettings, surveying, conveyancing and advice on mortgages and non-investment insurance products.
IME: Price=8. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Immedia Group provides music and communications solutions helping companies in retail, banking, leisure and hospitality, energy, sport, tourism, and education achieving customer’s expectations by creating sensory content and marketing communications.
GMS: Price=6.2. Cap=22m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Gulf Marine Services is a provider of self-propelled, self-elevating accommodation jack-up barges in the Middle East and globally. The Company's business segments are Small Class vessels, Mid-Size Class vessels, Large Class vessels, and Other vessels.
* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk/index.aspx?limit=-1
@MrContrarian
read it first on Twitter